-
Roche Holding AG’s Avastin delayed progression of ovarian cancer and cut the rate of death in some women with the disease in two studies. They didn’t show that the $58,000-a-year therapy could improve survival.
-
Dennis Prestholdt credits the past three years of his life to Johnson & Johnson ’s Zytiga, the first prostate cancer pill to win U.S. marketing approval in a family of treatments that offer new ways to stymie the male hormones that fuel tumor growth.
-
Optimer Pharmaceuticals Inc. won U.S. approval for the first antibiotic in a quarter-century that fights a deadly bacterium linked to intestinal infections often caught in hospitals.
-
Intermune Inc. , which won European approval Feb. 28 for Esbriet, will start selling the lung- disease drug in September in Germany and in other parts of Europe next year, Chief Executive Officer Dan Welch said.
-
Roche Holding AG scientists may have found a way to overcome a blood barrier that keeps drugs from directly entering the brain, potentially opening new pathways to attack Alzheimer’s disease.
-
A Roche Holding AG experimental drug called MetMab, used with another medicine, extended the lives of lung-cancer patients whose tumors had high levels of a protein known to trigger the disease and help it spread, a study found.
-
Vivus Inc. said its effort to win regulatory approval for weight-loss pill Qnexa may be helped by a study showing little risk of birth defects in children of women who took one of the medicine’s ingredients.
-
Optimer Pharmaceuticals Inc. ’s Dificid is on track to lead as many as five new antibiotics onto the market over the next three years as a surge in drug- resistant germs stokes the need for new medicines.
-
Exelixis Inc. ’s experimental pill reduced malignant growths in the bones of 86 percent of men with prostate cancer and cut the spread of tumor cells in one-fourth of women with ovarian cancer in a company study.
-
A 10-year-old girl with a deadly blood clot underwent a life-saving surgery that showed the power of using stem cells to regenerate healthy organs.